RecruitingNCT07280364

Metabolomics in the Diagnosis and Treatment of Asthma in Children

Sponsor

I.M. Sechenov First Moscow State Medical University

Enrollment

100 participants

Start Date

Mar 13, 2024

Study Type

OBSERVATIONAL

Conditions

Asthma

Summary

The goal of this observational study is to learn about the metabolomic profile of blood and urine in children 12-17 years with asthma. The main question it aims to answer is: • Are there metabolites in the blood and urine that are specific for asthma exacerbation? Participants already receive standard therapy as part of their regular medical care for asthma.

Eligibility

Min Age: 12 YearsMax Age: 17 Years

Plain Language Summary

Simplified for easier understanding

This study is using a technology called metabolomics — which analyzes hundreds of chemical compounds in the body — to better understand how asthma affects children's metabolism and how it changes with treatment. **You may be eligible if...** - You are 12–17 years old - You have a confirmed diagnosis of asthma - You are willing to participate and have given consent (with parental consent if applicable) **You may NOT be eligible if...** - You are under 12 years old - You do not have a confirmed asthma diagnosis - You have other severe health conditions (such as serious metabolic, hormonal, or organ diseases) - You or your guardian withdraw consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.